Sales are forecast to reach approximately US$5bn by 2015
GMP certification and strong downstream demand for pharmaceutical equipment in China has driven steady growth in sales volume and technological investment in recent years, according to a new report by Companiesandmarkets.com.
In 2011, China's pharmaceutical equipment industry produced RMB15.4bn (US$2.5bn; €1.91bn) worth of equipment, representing a year-on-year increase of 23.5%, the China Pharmaceutical Equipment Industry Report, 2012–2015, reveals. Likewise, sales totalled RMB16.1bn, an increase of 25.2% annually. Total profit totalled RMB1.82bn, which was up by 19.3% over the previous year with gross margin of the industry rising to 11.3%.
The leading companies operating in China's pharmaceutical equipment market primarily concentrate on drying, packaging and sterilisation. Shinva Medical Instrument, Shanghai Tofflon Science and Technology, Truking Technology and Hunan China Sun Pharmaceutical Machinery are the leading companies in this area in China.
It is anticipated that market sales growth will slow down a little with total market sales for pharmaceutical equipment totalling RMB31.41bn by the end of 2015.
The market is relatively consolidated with the top four companies in China attaining a market share of approximately 25%. Shinva Medical is the market leader, reporting RMB2.11bn revenue in 2011 with a market share of 13.1%.
The report provides information on status analysis, including industry development, industry concentration, entry barriers, competition pattern, technical status and development trends.